Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Single-cell meta-analyses reveal responses of tumor-reactive CXCL13+ T cells to immune-checkpoint blockade
Baolin Liu, Yuanyuan Zhang, Dongfang Wang, et al.
Nature Cancer (2022) Vol. 3, Iss. 9, pp. 1123-1136
Closed Access | Times Cited: 167

Showing 1-25 of 167 citing articles:

The technological landscape and applications of single-cell multi-omics
Alev Baysoy, Zhiliang Bai, Rahul Satija, et al.
Nature Reviews Molecular Cell Biology (2023) Vol. 24, Iss. 10, pp. 695-713
Open Access | Times Cited: 431
Dynamics and specificities of T cells in cancer immunotherapy
Giacomo Oliveira, Catherine J. Wu
Nature reviews. Cancer (2023) Vol. 23, Iss. 5, pp. 295-316
Closed Access | Times Cited: 232
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Assaf Magen, Pauline Hamon, Nathalie Fiaschi, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1389-1399
Closed Access | Times Cited: 182
Pan-cancer T cell atlas links a cellular stress response state to immunotherapy resistance
Yanshuo Chu, Enyu Dai, Yating Li, et al.
Nature Medicine (2023) Vol. 29, Iss. 6, pp. 1550-1562
Closed Access | Times Cited: 171
Stem-like exhausted and memory CD8+ T cells in cancer
Thomas Gebhardt, Simone L. Park, Ian A. Parish
Nature reviews. Cancer (2023) Vol. 23, Iss. 11, pp. 780-798
Closed Access | Times Cited: 63
Augmenting Immunotherapy via Bioinspired MOF‐Based ROS Homeostasis Disruptor with Nanozyme‐Cascade Reaction
Ruifang Wang, Maosong Qiu, Lei Zhang, et al.
Advanced Materials (2023) Vol. 35, Iss. 49
Closed Access | Times Cited: 61
Progenitor-like exhausted SPRY1+CD8+ T cells potentiate responsiveness to neoadjuvant PD-1 blockade in esophageal squamous cell carcinoma
Zhichao Liu, Yaru Zhang, Ning Ma, et al.
Cancer Cell (2023) Vol. 41, Iss. 11, pp. 1852-1870.e9
Open Access | Times Cited: 50
Human lung cancer harbors spatially organized stem-immunity hubs associated with response to immunotherapy
Jonathan Chen, Linda T. Nieman, Maxwell Spurrell, et al.
Nature Immunology (2024) Vol. 25, Iss. 4, pp. 644-658
Open Access | Times Cited: 49
Transitioning single-cell genomics into the clinic
Jennifer Lim, Venessa Chin, Kirsten A. Fairfax, et al.
Nature Reviews Genetics (2023) Vol. 24, Iss. 8, pp. 573-584
Closed Access | Times Cited: 44
Accelerating the understanding of cancer biology through the lens of genomics
Dongfang Wang, Baolin Liu, Zemin Zhang
Cell (2023) Vol. 186, Iss. 8, pp. 1755-1771
Closed Access | Times Cited: 43
Clinical and translational attributes of immune-related adverse events
Karijn P.M. Suijkerbuijk, Mick J M van Eijs, Femke van Wijk, et al.
Nature Cancer (2024) Vol. 5, Iss. 4, pp. 557-571
Closed Access | Times Cited: 33
Pan-cancer single-cell dissection reveals phenotypically distinct B cell subtypes
Yang Yu, Xueyan Chen, Jieying Pan, et al.
Cell (2024) Vol. 187, Iss. 17, pp. 4790-4811.e22
Open Access | Times Cited: 30
Spatiotemporal single-cell analysis decodes cellular dynamics underlying different responses to immunotherapy in colorectal cancer
Yuqing Chen, Dongfang Wang, Yingjie Li, et al.
Cancer Cell (2024) Vol. 42, Iss. 7, pp. 1268-1285.e7
Open Access | Times Cited: 21
Interferon subverts an AHR–JUN axis to promote CXCL13+ T cells in lupus
Calvin Law, Vanessa Sue Wacleche, Ye Cao, et al.
Nature (2024) Vol. 631, Iss. 8022, pp. 857-866
Closed Access | Times Cited: 20
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
Minae An, Arnav Mehta, Byung‐Hoon Min, et al.
Cancer Discovery (2024) Vol. 14, Iss. 5, pp. 766-785
Open Access | Times Cited: 17
Neoadjuvant PARPi or chemotherapy in ovarian cancer informs targeting effector Treg cells for homologous-recombination-deficient tumors
Yikai Luo, Yu Xia, Dan Liu, et al.
Cell (2024) Vol. 187, Iss. 18, pp. 4905-4925.e24
Open Access | Times Cited: 17
CD4+ T cells produce IFN-I to license cDC1s for induction of cytotoxic T-cell activity in human tumors
Xin Lei, Daniël C. de Groot, Marij J.P. Welters, et al.
Cellular and Molecular Immunology (2024) Vol. 21, Iss. 4, pp. 374-392
Open Access | Times Cited: 16
Leveraging Single-Cell Multi-Omics to Decode Tumor Microenvironment Diversity and Therapeutic Resistance
Hussein Sabit, Borros Arneth, Timothy M. Pawlik, et al.
Pharmaceuticals (2025) Vol. 18, Iss. 1, pp. 75-75
Open Access | Times Cited: 3
Biological and clinical significance of tumour-infiltrating lymphocytes in the era of immunotherapy: a multidimensional approach
Miguel López de Rodas, María Villalba, Miguel F. Sanmamed, et al.
Nature Reviews Clinical Oncology (2025)
Closed Access | Times Cited: 3
Supervised discovery of interpretable gene programs from single-cell data
Russell Kunes, Thomas Walle, Max Land, et al.
Nature Biotechnology (2023) Vol. 42, Iss. 7, pp. 1084-1095
Open Access | Times Cited: 40
Phenotypic diversity of T cells in human primary and metastatic brain tumors revealed by multiomic interrogation
Vladimir Wischnewski, Roeltje R. Maas, Paola Guerrero Aruffo, et al.
Nature Cancer (2023) Vol. 4, Iss. 6, pp. 908-924
Open Access | Times Cited: 36
Defining and using immune archetypes to classify and treat cancer
Alexis J. Combes, Bushra Samad, Matthew F. Krummel
Nature reviews. Cancer (2023) Vol. 23, Iss. 7, pp. 491-505
Closed Access | Times Cited: 31
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer
Cem Sievers, Marco Craveiro, Jay Friedman, et al.
Cancer Cell (2023) Vol. 41, Iss. 5, pp. 887-902.e5
Open Access | Times Cited: 28
The screening, identification, design and clinical application of tumor-specific neoantigens for TCR-T cells
Jianping Li, Zhiwen Xiao, Donghui Wang, et al.
Molecular Cancer (2023) Vol. 22, Iss. 1
Open Access | Times Cited: 27
Cellular and molecular waypoints along the path of T cell exhaustion
Xin Lan, Caitlin C. Zebley, Ben Youngblood
Science Immunology (2023) Vol. 8, Iss. 87
Open Access | Times Cited: 25
Page 1 - Next Page

Scroll to top